SCHEMBL6024591

SCHEMBL6024591

CCOC(CCCc1ccccc1)(OCC)OCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
CHRM1 P11229 1/20 0.44
DRD1 P21728 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
ADRA1A P35348 1/20 0.44
OPRM1 P35372 1/20 0.44
DRD3 P35462 1/20 0.44
SLC6A3 Q01959 1/20 0.44
KCNH2 Q12809 1/20 0.44
IDO1 P14902 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SIGMAR1 Q99720 4/20 0.41
MAOA P21397 1/20 0.41
HPGD P15428 1/20 0.41
AOC3 Q16853 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6023404 0.88 TP53 (0.41) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL6303238 0.75 SLC6A2 (0.46) SLC6A2
SCHEMBL28202908 0.73 TDP1 (0.40) L3MBTL1MEN1KMT2AHPGD
SCHEMBL4155150 0.73 TDP1 (0.40) L3MBTL1MEN1KMT2AHPGD
SCHEMBL11703445 0.73 SIGMAR1 (0.38) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL15736515 0.73 TAAR1 (0.36) KCNH2L3MBTL1KMT2ASIGMAR1AOC3
SCHEMBL6685035 0.73 L3MBTL1 (0.48) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL114790 0.72 TP53 (0.37) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL11047843 0.71 L3MBTL1 (0.47) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL8374954 0.71 CA1 (0.40) CHRM2HTR1AADRA2ACHRM1DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060106037-A1 Purin-6-one-derivatives ALTANA PHARMA AG (DE) 2006-05-18 US disclosed
EP-1601675-A1 PURIN-6-ONE-DERIVATIVES ALTANA Pharma AG (DE) 2005-12-07 EP disclosed
WO-2004089953-A1 PURIN-6-ONE-DERIVATIVES ALTANA PHARMA AG (DE) 2004-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106037-A1 Purin-6-one-derivatives PDE4B, PDE4A, PDE2A CHRM2 49/4885HTR1A 530/4885ADRA2A 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.